Source document or public record

FDA 510(k) K200107 — epoc Blood Analysis System

FDA 510(k) index record K200107. Device: epoc Blood Analysis System. Applicant as listed: Epocal, Inc.. Decision date: 2020-06-05.

OtherU.S. Food and Drug Administration (FDA)2020-06-05

Source

"device_name": "epoc Blood Analysis System"

This entry describes what the document covers; the document itself is the authority. Listing it is not agreement with its conclusions.

Review and references

Reviewer

Automated FDA record verification

Published

2026-10-20

Updated

2026-10-20

Disclaimer

professional use

FDA 510(k) public index record K200107.

Device name: epoc Blood Analysis System. Applicant as listed: Epocal, Inc..

Decision date: 2020-06-05. Decision wording: Substantially Equivalent.

Product code: CHL. Regulation: 21 CFR 862.1120. Medical specialty: Clinical Chemistry.

This page reproduces regulator index metadata. The applicant field identifies the submitter and is not a manufacturer identity check. Consult the original FDA record for the decision and associated documents; this index does not verify current commercial availability or clinical performance.

Interested in these solutions?

Submit a sourcing request with the assays, volumes, and timeline of your own project.